Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/BMYB34 stock hub

BVMF/BMYB34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/BMYB34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

561.7B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/BMYB34

In the news

Latest news · BVMF/BMYB34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.1

P25 11.3P50 14.6P75 19.6

Trailing P/E14.8

P25 15.2P50 21.5P75 27.3

ROE38.7

P25 5.3P50 12.3P75 22.5

ROIC20.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/BMYB34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	32,500
Employees Change	-1,600%
Employees Change Percent	-4.69
Enterprise value	BRL 736.1B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 561.7B
Price	BRL 275
Price currency	BRL
Rev Per Employee	7,782,069.58x
Sector	Healthcare
Sic	2834
Symbol	bvmf/BMYB34
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.76%
EV Earnings	19.4x
EV/EBIT	9.77x
EV/EBITDA	7.75x
EV/FCF	11.85x
EV/Sales	3.1x
FCF yield	11.06%
Forward P/E	9.08x
P/B ratio	5.36x
P/E ratio	14.8x
P/S ratio	2.22x
PE Ratio10 Y	39.48x
PE Ratio3 Y	16.73x
PE Ratio5 Y	19.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.56%
EBITDA Margin	39.14%
FCF margin	24.56%
Gross margin	71.98%
Gross Profit	BRL 182.1B
Gross Profit Growth	-1.91%
Gross Profit Growth Q	-1.25%
Gross Profit Growth3 Y	-1.01%
Gross Profit Growth5 Y	0.44%
Net Income	BRL 38B
Net Income Growth	34.25%
Net Income Growth Q	9%
Net Income Growth3 Y	-0.16%
Pretax Margin	19.79%
Profit Margin	15.01%
Profit Per Employee	BRL 1.2M
ROA	10.69
Roa5y	6.51
ROCE	22.73
ROE	38.73
Roe5y	13.18
ROIC	20.88
Roic5y	14.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.23%
Cagr1y	3.81%
Cagr3y	-3.47%
Cagr5y	-1.45%
Div CAGR10	9.02%
Div CAGR3	4.91%
Div CAGR5	5.27%
EPS Growth	33.74
EPS Growth Q	9.17
EPS Growth3 Y	1.37
FCF Growth	-9%
FCF Growth Q	-55.31%
FCF Growth3 Y	2.43%
FCF Growth5 Y	-2.04%
OCF Growth	-7.02%
OCF Growth Q	-43.5%
OCF Growth10 Y	29.83%
OCF Growth3 Y	2.87%
OCF Growth5 Y	-0.93%
Revenue Growth	1.78x
Revenue Growth Q	2.57x
Revenue Growth3 Y	1.88x
Revenue Growth5 Y	2.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.54
Assets	BRL 451.1B
Cash	BRL 54.7B
Current Assets	BRL 133.7B
Current Liabilities	BRL 94.1B
Debt	BRL 242.2B
Debt EBITDA	BRL 2.4
Debt Equity	BRL 2.31
Debt FCF	BRL 3.9
Equity	BRL 104.9B
Interest Coverage	8.48
Liabilities	BRL 346.3B
Long Term Assets	BRL 317.4B
Long Term Liabilities	BRL 252.1B
Net Cash	BRL -185.6B
Net Cash By Market Cap	BRL -33.04
Net Debt EBITDA	BRL 1.88
Net Debt Equity	BRL 1.77
Net Debt FCF	BRL 2.99
Tangible Book Value	BRL -103.9B
Tangible Book Value Per Share	BRL -50.88
WACC	4.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	5.01
Net Working Capital	BRL 370.4M
Quick ratio	1.18
Working Capital	BRL 42B
Working Capital Turnover	BRL 34.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.47%
Dividend Growth	-5.74%
Dividend Growth Years	4%
Dividend per share	BRL 8.71
Dividend Years	14
Dividend Yield	3.17%
Ex Div Date	2026-04-02
Last Dividend	BRL 2.06
Payout Frequency	Quarterly
Payout Ratio	69.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	37.42%
1Y total return	3.81%
200-day SMA	279.2
3Y total return	-10.07%
50-day SMA	304.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-7.04%
All Time High	431.8
All Time High Change	-36.31%
All Time High Date	2022-11-25
All Time Low	65.32
All Time Low Change	321.04%
All Time Low Date	2012-12-27
ATR	6.64
Beta	0.26
Ch YTD	-8.35
High	275.2
High52	337.5
High52 Date	2026-03-20
High52ch	-18.52%
Low	274.8
Low52	227.9
Low52 Date	2025-10-29
Low52ch	20.69%
Ma50ch	-9.77%
Price vs 200-day SMA	-1.51%
RSI	36.35
RSI Monthly	47.17
RSI Weekly	46.06
Sharpe ratio	-0.04x
Sortino ratio	0.07
Total Return	2.7%
Tr YTD	-7.05
Tr1m	-7.84%
Tr1w	-3.46%
Tr3m	-14.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 79.8B
Operating Income Growth	38.03
Operating Income Growth Q	7.35
Operating Income Growth3 Y	16.68
Operating Income Growth5 Y	15.03
Operating margin	31.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,038,886,888%
Net Borrowing	-28,119,052,400
Shares Insiders	0.05%
Shares Institutions	81.98%
Shares Qo Q	0.29%
Shares Yo Y	0.47%
Short Ratio	2.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 59.2B
Average Volume	8.15x
Bv Per Share	51.27
CAPEX	BRL -7.3B
Ch10y	9.17
Ch1m	-7.84
Ch1w	-3.46
Ch1y	0.56
Ch3m	-14.81
Ch3y	-18.01
Ch5y	-18.66
Ch6m	9.89
Change	-2.08%
Change From Open	-0.09
Close	280.8
Days Gap	-1.99
Depreciation Amortization	18,059,685,000
Dollar Volume	2,200
Earnings Date	2026-04-30
EBIT	BRL 79.8B
EBITDA	BRL 99B
EPS	BRL 18.63
F Score	7
FCF	BRL 62.1B
FCF EV Yield	8.44x
Financing CF	-56,940,553,375
Fiscal Year End	December
Founded	1,887
Goodwill	106,834,708,000
Graham Number	146.51319
Graham Upside	-46.72
Income Tax	BRL 12.1B
Investing CF	-19,635,752,900
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	BRL 92.91
Lynch Upside	-66.22
Ma150	272.9
Ma150ch	0.78%
Ma20	299.5
Ma20ch	-8.18%
Net CF	-6,740,008,700
Open	275.2
P FCF Ratio	9.04
P OCF Ratio	8.09
Payment Date	2026-05-12
Position In Range	45.45
Ppne	45,141,841,200
Price Date	2026-05-08
Price EBITDA	BRL 5.67
Relative Volume	0.98x
Revenue	252,917,261,450x
SBC By Revenue	1.14x
Share Based Comp	2,895,282,375
Tax By Revenue	4.79x
Tax Rate	24.22%
Tr6m	11.45%
Volume	8
Z Score	2.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/BMYB34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$8.71 annual per share

Payout ratio

+69.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.3%

4 consecutive years of growth

Total shareholder yield

+2.7%

Next ex-dividend date: 2026-04-02

Performance

BVMF/BMYB34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/BMYB34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/BMYB34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.3

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

-0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/BMYB34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/BMYB34 stock rating?

bvmf/BMYB34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/BMYB34 analysis?

The full report lives at /stocks/bvmf/BMYB34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/BMYB34?

The latest report frames bvmf/BMYB34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/BMYB34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.